Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03730012
Brief Title: A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML)

First Submitted : November 1, 2018
First Submitted that Met QC Criteria : November 1, 2018
First Posted : November 5, 2018

Last Update Submitted that Met QC Criteria : April 8, 2021
Last Update Posted : April 9, 2021 (Estimate)